A citation-based method for searching scientific literature

Barbara Burtness, David Ilson, Syma Iqbal. Am Soc Clin Oncol Educ Book 2014
Times Cited: 5







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Preoperative chemoradiotherapy for esophageal or junctional cancer.
P van Hagen, M C C M Hulshof, J J B van Lanschot, E W Steyerberg, M I van Berge Henegouwen, B P L Wijnhoven, D J Richel, G A P Nieuwenhuijzen, G A P Hospers, J J Bonenkamp,[...]. N Engl J Med 2012
60

Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.
Austin M Dulak, Petar Stojanov, Shouyong Peng, Michael S Lawrence, Cameron Fox, Chip Stewart, Santhoshi Bandla, Yu Imamura, Steven E Schumacher, Erica Shefler,[...]. Nat Genet 2013
536
40

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh,[...]. Lancet 2010
40

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
Katrin M Sjoquist, Bryan H Burmeister, B Mark Smithers, John R Zalcberg, R John Simes, Andrew Barbour, Val Gebski. Lancet Oncol 2011
40

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
Maria Secrier, Xiaodun Li, Nadeera de Silva, Matthew D Eldridge, Gianmarco Contino, Jan Bornschein, Shona MacRae, Nicola Grehan, Maria O'Donovan, Ahmad Miremadi,[...]. Nat Genet 2016
225
40

Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.
Vera Oppedijk, Ate van der Gaast, Jan J B van Lanschot, Pieter van Hagen, Rob van Os, Caroline M van Rij, Maurice J van der Sangen, Jannet C Beukema, Heidi Rütten, Patty H Spruit,[...]. J Clin Oncol 2014
288
40

Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Andrew R Davies, James A Gossage, Janine Zylstra, Fredrik Mattsson, Jesper Lagergren, Nick Maisey, Elizabeth C Smyth, David Cunningham, William H Allum, Robert C Mason. J Clin Oncol 2014
167
40


Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
David Cunningham, William H Allum, Sally P Stenning, Jeremy N Thompson, Cornelis J H Van de Velde, Marianne Nicolson, J Howard Scarffe, Fiona J Lofts, Stephen J Falk, Timothy J Iveson,[...]. N Engl J Med 2006
40

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.
Marc Ychou, Valérie Boige, Jean-Pierre Pignon, Thierry Conroy, Olivier Bouché, Gilles Lebreton, Muriel Ducourtieux, Laurent Bedenne, Jean-Michel Fabre, Bernard Saint-Aubert,[...]. J Clin Oncol 2011
40

Age and clinical decision making in oncology patients.
S B Yellen, D F Cella, W T Leslie. J Natl Cancer Inst 1994
275
20

Increasing age is a predictor of short-term outcomes in esophagectomy: a propensity score adjusted analysis.
Christopher C Stahl, Dennis J Hanseman, Koffi Wima, Jeffrey M Sutton, Gregory C Wilson, Samuel F Hohmann, Shimul A Shah, Daniel E Abbott. J Gastrointest Surg 2014
8
20


Multidisciplinary cancer care may impact on the postoperative mortality and survival of patients with oesophageal and oesophagogastric junction cancer: a retrospective cohort study.
M Galán, L Farran, L Aliste, G Hormigo, H Aranda, C Bettonica, A M Boladeras, J M Botargues, M Calvo, G Creus,[...]. Clin Transl Oncol 2015
6
20

Cancer burden in the year 2000. The global picture.
D M Parkin, F I Bray, S S Devesa. Eur J Cancer 2001
20

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.
Michael Stahl, Martin K Walz, Martin Stuschke, Nils Lehmann, Hans-Joachim Meyer, Jorge Riera-Knorrenschild, Peter Langer, Rita Engenhart-Cabillic, Michael Bitzer, Alfred Königsrainer,[...]. J Clin Oncol 2009
633
20


7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.
Thomas W Rice, Eugene H Blackstone, Valerie W Rusch. Ann Surg Oncol 2010
631
20

Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.
Ai Kubo, Douglas A Corley, Christopher D Jensen, Rubinder Kaur. Nutr Res Rev 2010
65
20


Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.
Michael Stahl, Martin Stuschke, Nils Lehmann, Hans-Joachim Meyer, Martin K Walz, Siegfried Seeber, Bodo Klump, Wilfried Budach, Reinhard Teichmann, Marcus Schmitt,[...]. J Clin Oncol 2005
896
20

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.
Val Gebski, Bryan Burmeister, B Mark Smithers, Kerwyn Foo, John Zalcberg, John Simes. Lancet Oncol 2007
916
20

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
Joel Tepper, Mark J Krasna, Donna Niedzwiecki, Donna Hollis, Carolyn E Reed, Richard Goldberg, Krystyna Kiel, Christopher Willett, David Sugarbaker, Robert Mayer. J Clin Oncol 2008
945
20

Identification of genomic alterations in oesophageal squamous cell cancer.
Yongmei Song, Lin Li, Yunwei Ou, Zhibo Gao, Enmin Li, Xiangchun Li, Weimin Zhang, Jiaqian Wang, Liyan Xu, Yong Zhou,[...]. Nature 2014
697
20

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
M Stahl, C Mariette, K Haustermans, A Cervantes, D Arnold. Ann Oncol 2013
164
20

Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.
Norihisa Uemura, Tadashi Kondo. World J Gastrointest Pathophysiol 2014
15
20

Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis.
E Bollschweiler, R Metzger, U Drebber, S Baldus, D Vallböhmer, M Kocher, A H Hölscher. Ann Oncol 2009
82
20


[Surgical outcomes of esophageal cancer resection since the development of an Oesophagogastric Tumour Board].
Leandre Farran Teixidor, Josep Llop Talaverón, Maica Galán Guzmán, Humberto Aranda Danso, Mónica Miró Martín, Carla Bettónica Larrañaga, Fernando Estremiana García, Sebastiano Biondo. Cir Esp 2013
4
25

Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use?
R M Hermann, O Horstmann, F Haller, C Perske, H Christiansen, A Hille, H Schmidberger, L Füzesi. Dis Esophagus 2006
39
20

Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015.
C Castro, C Bosetti, M Malvezzi, P Bertuccio, F Levi, E Negri, C La Vecchia, N Lunet. Ann Oncol 2014
95
20

Esophageal cancer: a critical evaluation of systemic second-line therapy.
Christiane Maria Rosina Thallinger, Markus Raderer, Michael Hejna. J Clin Oncol 2011
87
20

Esophageal carcinoma.
Anil K Rustgi, Hashem B El-Serag. N Engl J Med 2014
777
20


Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma.
Y Kawaguchi, K Kono, K Mimura, F Mitsui, H Sugai, H Akaike, H Fujii. Br J Cancer 2007
60
20

Leptin and cancer.
Cecilia Garofalo, Eva Surmacz. J Cell Physiol 2006
424
20

Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Kaiyan Chen, Ziyu Zhu, Nan Zhang, Guoping Cheng, Fanrong Zhang, Jiaoyue Jin, Junzhou Wu, Lisha Ying, Weimin Mao, Dan Su. Med Sci Monit 2017
19
20

Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers.
Justin K Smit, Hette Faber, Maarten Niemantsverdriet, Mirjam Baanstra, Johan Bussink, Harry Hollema, Ronald P van Os, John Th M Plukker, Robert P Coppes. Radiother Oncol 2013
54
20

The cellular and molecular bases of leptin and ghrelin resistance in obesity.
Huxing Cui, Miguel López, Kamal Rahmouni. Nat Rev Endocrinol 2017
196
20

Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma.
Fergus Noble, Toby Mellows, Leo H McCormick Matthews, Adrian C Bateman, Scott Harris, Timothy J Underwood, James P Byrne, Ian S Bailey, Donna M Sharland, Jamie J Kelly,[...]. Cancer Immunol Immunother 2016
73
20

Comparison of pretherapeutic and posttherapeutic expression levels of chemotherapy-associated genes in adenocarcinomas of the esophagus treated by 5-fluorouracil- and cisplatin-based neoadjuvant chemotherapy.
Rupert Langer, Katja Specht, Karen Becker, Philipp Ewald, Katja Ott, Florian Lordick, Jörg-Rüdiger Siewert, Heinz Höfler. Am J Clin Pathol 2007
23
20

Immunotherapy for Gastroesophageal Cancer.
Emily F Goode, Elizabeth C Smyth. J Clin Med 2016
35
20

Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia.
Charles T Miller, Justin R Moy, Lin Lin, Matthew Schipper, Daniel Normolle, Dean E Brenner, Mark D Iannettoni, Mark B Orringer, David G Beer. Clin Cancer Res 2003
114
20

Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment.
Carmine Carbone, Anna Tamburrino, Geny Piro, Federico Boschi, Ivana Cataldo, Marco Zanotto, Maria M Mina, Silvia Zanini, Andrea Sbarbati, Aldo Scarpa,[...]. Anticancer Drugs 2016
25
20

Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study.
S Watson, P Validire, P Cervera, N Zorkani, A Scriva, F Lemay, C Tournigand, T Perniceni, M-L Garcia, M Bennamoun,[...]. Ann Oncol 2013
31
20

Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer.
Andrew B C Crumley, James J Going, Mustafa Hilmy, Sumanta Dutta, Claire Tannahill, Margaret McKernan, Joanne Edwards, Robert C Stuart, Donald C McMillan. Ann Surg Oncol 2011
18
20

Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma.
Dagmar Kollmann, Desislava Ignatova, Julia Jedamzik, Yun-Tsan Chang, Gerd Jomrich, Matthias Paireder, Ivan Kristo, Dmitry Kazakov, Michal Michal, Antonio Cozzio,[...]. Ann Surg Oncol 2017
21
20

Adipocytokines and cancer.
D Housa, J Housová, Z Vernerová, M Haluzík. Physiol Res 2006
209
20

NF-kappa B as a target for cancer therapy.
Davide Melisi, Paul J Chiao. Expert Opin Ther Targets 2007
84
20

IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation.
Zhuonan Zhuang, Huai-Qiang Ju, Mitzi Aguilar, Takashi Gocho, Hao Li, Tomonori Iida, Harold Lee, Xiaoqiang Fan, Haijun Zhou, Jianhua Ling,[...]. Clin Cancer Res 2016
73
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.